Zuellig Pharma is one of the largest healthcare services groups in Asia and its purpose is to make healthcare more accessible. The company provides world-class distribution, digital and commercial services to support growing healthcare needs in the region. Established almost a hundred years ago, Zuellig Pharma has become a US$13 billion business. Today, it serves more than 350,000 medical facilities and works with over 500 clients including the top 20 pharmaceutical companies in the world.
With lockdowns arising from the current COVID-19 pandemic, Zuellig Pharma is striving to ensure that essential medicines and healthcare supplies continue to be accessible to those who need them the most. While the pandemic has resulted in significant disruptions in the healthcare supply chain, the company has implemented robust risk management and business continuity plans and harnessed digital tools that have enabled them to continue serving their partners, clients, customers and patients during this critical time.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical/biopharmaceutical manufacturing science and regulation, so members can better serve patients.www.pda.org/@company